Next-Generation CAR T-cell Therapies is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 174 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P01CA214278
NIH
Grant: U54CA244711
National Institutes of Health
Grant: 3U54CA244711-01S2
Engineering the Next Generation of T Cells
National Institutes of Health
Grant: 3P01CA214278-02S1
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
FWCI
14.89
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
Additional file 1 of First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
Additional file 1 of Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy
Additional file 1 of Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy
Additional file 1 of M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors
Additional file 1 of M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors